Literature DB >> 9893092

Stroke risk in an elderly population with atrial fibrillation.

W M Feinberg1, R A Kronmal, A B Newman, M A Kraut, E G Bovill, L Cooper, R G Hart.   

Abstract

Patients with nonvalvular atrial fibrillation (AF) have an increased risk of stroke, but the absolute rate of stroke varies widely depending on coexistent vascular disease. We assessed the stroke rate and predictive value of two published schemes for stroke risk stratification in a population-derived cohort of 259 elderly people with nonvalvular AF followed for a median of 5.3 years. The rate of ischemic stroke was 2.8% per year (95% confidence interval [CI] 1.9, 3.9). Thirty-one percent were predicted to be at low risk, and their stroke rate was 1.7% per year (95% CI 0.6, 3.8). Many people with AF in this population-derived cohort had relatively low rates of stroke. Further studies to reliably stratify stroke risk in patients with AF are needed.

Entities:  

Mesh:

Year:  1999        PMID: 9893092      PMCID: PMC1496435          DOI: 10.1046/j.1525-1497.1999.00281.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  5 in total

1.  Anticoagulation therapy for patients with atrial fibrillation.

Authors:  R G Hart
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

2.  Adverse events associated with anticoagulation therapy in the periendoscopic period.

Authors:  Lauren B Gerson; LeAnn Michaels; Nighat Ullah; Brian Gage; Luke Williams
Journal:  Gastrointest Endosc       Date:  2010-06       Impact factor: 9.427

Review 3.  Atrial fibrillation in the elderly: facts and management.

Authors:  Guy Chatap; Karine Giraud; Jean-Pierre Vincent
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 4.  Stroke prevention in atrial fibrillation.

Authors:  R G Hart
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

Review 5.  Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States.

Authors:  Kamakshi Lakshminarayan; David C Anderson; Charles A Herzog; Adnan I Qureshi
Journal:  Neurologist       Date:  2008-05       Impact factor: 1.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.